RTU-1096

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRTU-1096
Drug Alias NameRTU-1096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsDiabetic macular oedemaPsoriasisDermatitis, Atopic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSucampo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSucampo Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaPsoriasisDermatitis, Atopic +[4

Other Information

ATC CodeN/A
Related LinksN/A